Uploaded April 2026 | Updated November 2026, 7 hours ago
How can doctors diagnose heart attacks faster and more accurately without invasive testing?
In this fireside chat, Dr. Jeff Bander, Chief of Cardiology at Mount Sinai West, explains how magnetocardiography (MCG) could transform how hospitals evaluate patients with chest pain.
Each year, millions of people visit emergency departments with possible cardiac symptoms. Many fall into a diagnostic “gray zone,” where traditional tools like the EKG and blood biomarkers don’t provide clear answers. This uncertainty leads to delayed diagnoses, unnecessary admissions, and billions in healthcare costs.
Dr. Bander discusses how magnetocardiography, a non-invasive technology that measures the heart’s magnetic signals, may help clinicians:
-Detect cardiac events earlier
-Reduce unnecessary imaging and hospital stays
-Improve emergency department workflows
-Map cardiac activity in three dimensions
-Move beyond the limitations of traditional EKG testing
He also shares insights from research with SandboxAQ, evaluating MCG in one of New York City’s busiest emergency departments, and what this technology could mean for the future of cardiac care.
Looking ahead, Dr. Bander explores how advances in AI simulation and large quantitative models (LQMs) could further transform cardiovascular diagnostics.
Check it out now to learn more about SandboxAQ's investigational technology.
To learn more about MCG and the AQMed team, visit our website at sandboxaq.com/solutions/aqmed
The SandboxAQ magnetocardiography (MCG) system is an investigational device and is not yet cleared or approved by the FDA for commercial sale or clinical use.
Chapters:
00:00 Introduction: Why Magnetocardiography Could Change Cardiology
00:16 Meet Dr. Jeff Bander, Chief of Cardiology at Mount Sinai West
01:10 The Challenge: Diagnosing Chest Pain in the ER “Gray Zone”
01:41 Why Chest Pain Evaluation Costs Billions Each Year
02:18 Avoiding Missed Heart Attacks While Managing Risk
02:59 How Limited Imaging Resources Slow Diagnosis
04:18 Why Hospitals Need Faster Cardiac Decision Pathways
05:06 Troponin Tests and the Limits of Current Diagnostics
05:50 When Standard Tests Miss Hidden Cardiac Events
06:14 Connecting Clinical Need to Magnetocardiography
06:43 From Concept to Prototype: First Reactions to the Technology
07:31 Making Cardiac AI Tools Work in Real Emergency Rooms
08:32 Testing Magnetocardiography in a Busy NYC ER
09:09 Why Earlier MCG Systems Required Faraday Cages
09:33 Detecting Coronary Artery Disease vs Detecting Heart Attacks
10:32 The Fundamental Shift Beyond Traditional EKGs
11:12 Creating a 3D Map of the Heart with Magnetocardiography
11:58 Future Applications of Magnetic Cardiac Mapping
12:15 Large Quantitative Models and the Future of Cardiology
13:16 What Comes Next for Magnetic Sensing in Medicine
#sandboxaq #aqmed #lqms
How can doctors diagnose heart attacks faster and more accurately without invasive testing?
In this fireside chat, Dr. Jeff Bander, Chief of Cardiology at Mount Sinai West, explains how magnetocardiography (MCG) could transform how hospitals evaluate patients with chest pain.
Each year, millions of people visit emergency departments with possible cardiac symptoms. Many fall into a diagnostic “gray zone,” where traditional tools like the EKG and blood biomarkers don’t provide clear answers. This uncertainty leads to delayed diagnoses, unnecessary admissions, and billions in healthcare costs.
Dr. Bander discusses how magnetocardiography, a non-invasive technology that measures the heart’s magnetic signals, may help clinicians:
-Detect cardiac events earlier
-Reduce unnecessary imaging and hospital stays
-Improve emergency department workflows
-Map cardiac activity in three dimensions
-Move beyond the limitations of traditional EKG testing
He also shares insights from research with SandboxAQ, evaluating MCG in one of New York City’s busiest emergency departments, and what this technology could mean for the future of cardiac care.
Looking ahead, Dr. Bander explores how advances in AI simulation and large quantitative models (LQMs) could further transform cardiovascular diagnostics.
Check it out now to learn more about SandboxAQ's investigational technology.
To learn more about MCG and the AQMed team, visit our website at sandboxaq.com/solutions/aqmed
The SandboxAQ magnetocardiography (MCG) system is an investigational device and is not yet cleared or approved by the FDA for commercial sale or clinical use.
Chapters:
00:00 Introduction: Why Magnetocardiography Could Change Cardiology
00:16 Meet Dr. Jeff Bander, Chief of Cardiology at Mount Sinai West
01:10 The Challenge: Diagnosing Chest Pain in the ER “Gray Zone”
01:41 Why Chest Pain Evaluation Costs Billions Each Year
02:18 Avoiding Missed Heart Attacks While Managing Risk
02:59 How Limited Imaging Resources Slow Diagnosis
04:18 Why Hospitals Need Faster Cardiac Decision Pathways
05:06 Troponin Tests and the Limits of Current Diagnostics
05:50 When Standard Tests Miss Hidden Cardiac Events
06:14 Connecting Clinical Need to Magnetocardiography
06:43 From Concept to Prototype: First Reactions to the Technology
07:31 Making Cardiac AI Tools Work in Real Emergency Rooms
08:32 Testing Magnetocardiography in a Busy NYC ER
09:09 Why Earlier MCG Systems Required Faraday Cages
09:33 Detecting Coronary Artery Disease vs Detecting Heart Attacks
10:32 The Fundamental Shift Beyond Traditional EKGs
11:12 Creating a 3D Map of the Heart with Magnetocardiography
11:58 Future Applications of Magnetic Cardiac Mapping
12:15 Large Quantitative Models and the Future of Cardiology
13:16 What Comes Next for Magnetic Sensing in Medicine
#sandboxaq #aqmed #lqms










